Successful ovulation and pregnancy with pulsatile GnRH pump therapy in a polycystic ovary syndrome (PCOS) patient: a case report
Abstract
Polycystic ovary syndrome (PCOS) is one of the main causes of anovulatory infertility in women of reproductive age. The main ovulation induction protocols currently used in clinical practice primarily include letrozole, clomiphene, and gonadotropins. However, some patients may exhibit drug resistance or experience ovarian hyperstimulation syndrome (OHSS). In this article, we report a case of a 28-year-old patient with PCOS who had a normal body mass index (BMI) and normal level of luteinizing hormone (LH), failed to conceive with letrozole combined with human menopausal gonadotropin (HMG) but achieved successful ovulation and pregnancy with pulsatile gonadotropin-releasing hormone (GnRH) pump therapy, without OHSS or other adverse effects. This case demonstrates the potential efficacy of pulsatile GnRH pump therapy in PCOS patients who have failed to conceive with conventional ovulation induction, suggesting its potential as a promising alternative in clinical management.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.